385 related articles for article (PubMed ID: 11475436)
1. Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease.
Killestein J; Den Drijver BF; Van der Graaff WL; Uitdehaag BM; Polman CH; Van Lier RA
Mult Scler; 2001 Jun; 7(3):145-50. PubMed ID: 11475436
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
[TBL] [Abstract][Full Text] [Related]
3. Similar pro- and anti-inflammatory cytokine production in the different clinical forms of multiple sclerosis.
Durán I; Martínez-Cáceres EM; Brieva L; Tintoré M; Montalban X
Mult Scler; 2001 Jun; 7(3):151-6. PubMed ID: 11475437
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of interferon-β1b on cytokine patterns of CD4+ and CD8+ T cells derived from RRMS and PPMS patients.
Skrzipek S; Vogelgesang A; Bröker BM; Dressel A
Mult Scler; 2012 May; 18(5):674-8. PubMed ID: 22025329
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in in vitro pro-inflammatory cytokine production from peripheral blood of multiple sclerosis patients.
Nguyen LT; Ramanathan M; Weinstock-Guttman B; Baier M; Brownscheidle C; Jacobs LD
J Neurol Sci; 2003 May; 209(1-2):93-9. PubMed ID: 12686409
[TBL] [Abstract][Full Text] [Related]
6. Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS.
Killestein J; Eikelenboom MJ; Izeboud T; Kalkers NF; Adèr HJ; Barkhof F; Van Lier RA; Uitdehaag BM; Polman CH
J Neuroimmunol; 2003 Sep; 142(1-2):141-8. PubMed ID: 14512173
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
[TBL] [Abstract][Full Text] [Related]
8. Both CD4+ and CD8+ T-cells in syngeneic islet grafts in NOD mice produce interferon-gamma during beta-cell destruction.
Suarez-Pinzon W; Rajotte RV; Mosmann TR; Rabinovitch A
Diabetes; 1996 Oct; 45(10):1350-7. PubMed ID: 8826970
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in proinflammatory cytokine profiles of progressive patients in multiple sclerosis.
Eikelenboom MJ; Killestein J; Uitdehaag BM; Polman CH
Mult Scler; 2005 Oct; 11(5):520-3. PubMed ID: 16193888
[TBL] [Abstract][Full Text] [Related]
10. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
[TBL] [Abstract][Full Text] [Related]
11. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
Hamamcioglu K; Reder AT
Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
[TBL] [Abstract][Full Text] [Related]
12. Type 1 immune response in progressive multiple sclerosis.
Frisullo G; Plantone D; Marti A; Iorio R; Damato V; Nociti V; Patanella AK; Bianco A; Batocchi AP
J Neuroimmunol; 2012 Aug; 249(1-2):112-6. PubMed ID: 22613700
[TBL] [Abstract][Full Text] [Related]
13. Relative proportions of T-cell subpopulations and cytokines that mediate and regulate the adaptive immune response in patients with aggressive periodontitis.
Suárez LJ; Ocampo AM; Dueñas RE; Rodríguez A
J Periodontol; 2004 Sep; 75(9):1209-15. PubMed ID: 15515335
[TBL] [Abstract][Full Text] [Related]
14. Intracellular cytokines in blood T cells in lung transplant patients--a more relevant indicator of immunosuppression than drug levels.
Hodge G; Hodge S; Reynolds P; Holmes M
Clin Exp Immunol; 2005 Jan; 139(1):159-64. PubMed ID: 15606627
[TBL] [Abstract][Full Text] [Related]
15. Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS.
Balashov KE; Comabella M; Ohashi T; Khoury SJ; Weiner HL
Neurology; 2000 Jul; 55(2):192-8. PubMed ID: 10908889
[TBL] [Abstract][Full Text] [Related]
16. Analysis of effector CD4 (OX-40+) and CD8 (CD45RA+CD27-) T lymphocytes in active multiple sclerosis.
Hintzen RQ; Pot K; Paty D; Oger J
Acta Neurol Scand; 2000 Jan; 101(1):57-60. PubMed ID: 10660154
[TBL] [Abstract][Full Text] [Related]
17. Increased IL-13 but not IL-5 production by CD4-positive T cells and CD8-positive T cells in multiple sclerosis during relapse phase.
Ochi H; Osoegawa M; Wu XM; Minohara M; Horiuchi I; Murai H; Furuya H; Kira J
J Neurol Sci; 2002 Sep; 201(1-2):45-51. PubMed ID: 12163193
[TBL] [Abstract][Full Text] [Related]
18. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of co-polymer 1 on cytokine production by CD4 T cells in multiple sclerosis.
Fellay B; Chofflon M; Juillard C; Paunier AM; Landis T; Roth S; Gougeon ML
Immunology; 2001 Dec; 104(4):383-91. PubMed ID: 11899423
[TBL] [Abstract][Full Text] [Related]
20. Decreases in interleukin-4 secretion by invariant CD4(-)CD8(-)V alpha 24J alpha Q T cells in peripheral blood of patientswith relapsing-remitting multiple sclerosis.
Gausling R; Trollmo C; Hafler DA
Clin Immunol; 2001 Jan; 98(1):11-7. PubMed ID: 11141321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
